J.W. Burns & Co’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.53M Sell
11,468
-260
-2% -$71.9K 0.26% 68
2026
Q1
$3.46M Sell
11,728
-328
-3% -$97.4K 0.4% 54
2025
Q4
$3.29M Sell
12,056
-161
-1% -$43.7K 0.36% 56
2025
Q3
$3.3M Sell
12,217
-370
-3% -$101K 0.37% 55
2025
Q2
$3.47M Sell
12,587
-160
-1% -$43.5K 0.42% 54
2025
Q1
$3.38M Sell
12,747
-80
-0.6% -$19.7K 0.44% 52
2024
Q4
$2.98M Sell
12,827
-196
-2% -$45.1K 0.38% 57
2024
Q3
$2.87M Sell
13,023
-1,837
-12% -$380K 0.37% 56
2024
Q2
$2.92M Sell
14,860
-1,025
-6% -$212K 0.39% 57
2024
Q1
$3.42M Buy
15,885
+13
+0.1% +$2.73K 0.48% 49
2023
Q4
$3.34M Sell
15,872
-203
-1% -$43.3K 0.49% 50
2023
Q3
$3.22M Buy
16,075
+153
+1% +$30.4K 0.52% 50
2023
Q2
$2.95M Sell
15,922
-512
-3% -$94.6K 0.47% 53
2023
Q1
$3.15M Sell
16,434
-901
-5% -$163K 0.54% 53
2022
Q4
$2.92M Sell
17,335
-1,552
-8% -$270K 0.53% 53
2022
Q3
$3.35M Sell
18,887
-125
-0.7% -$24.7K 0.66% 47
2022
Q2
$3.89M Sell
19,012
-39
-0.2% -$8.27K 0.74% 41
2022
Q1
$4.53M Sell
19,051
-499
-3% -$117K 0.72% 43
2021
Q4
$4.47M Buy
19,550
+71
+0.4% +$15.6K 0.65% 46
2021
Q3
$3.77M Buy
19,479
+389
+2% +$78.8K 0.59% 49
2021
Q2
$4.06M Sell
19,090
-506
-3% -$107K 0.64% 47
2021
Q1
$4M Buy
19,596
+382
+2% +$75.2K 0.67% 45
2020
Q4
$3.5M Sell
19,214
-559
-3% -$95.1K 0.62% 47
2020
Q3
$3.31M Sell
19,773
-523
-3% -$88.1K 0.66% 45
2020
Q2
$3.3M Buy
20,296
+514
+3% +$92.1K 0.73% 43
2020
Q1
$3.42M Buy
19,782
+1,115
+6% +$222K 0.92% 34
2019
Q4
$3.75M Buy
18,667
+626
+3% +$128K 0.8% 41
2019
Q3
$3.81M Sell
18,041
-124
-0.7% -$25.9K 0.88% 39
2019
Q2
$3.53M Buy
18,165
+80
+0.4% +$14.7K 0.82% 42
2019
Q1
$2.98M Buy
18,085
+469
+3% +$82.9K 0.73% 46
2018
Q4
$3.31M Sell
17,616
-6
-0% -$1.11K 0.93% 34
2018
Q3
$3M Sell
17,622
-706
-4% -$119K 0.7% 47
2018
Q2
$3M Sell
18,328
-103
-0.6% -$16.8K 0.76% 45
2018
Q1
$2.98M Buy
18,431
+251
+1% +$40K 0.77% 47
2017
Q4
$2.65M Buy
18,180
+1,046
+6% +$149K 0.67% 52
2017
Q3
$2.33M Sell
17,134
-848
-5% -$107K 0.62% 55
2017
Q2
$2.25M Buy
17,982
+621
+4% +$74.3K 0.61% 58
2017
Q1
$2.06M Buy
17,361
+997
+6% +$120K 0.57% 61
2016
Q4
$1.89M Buy
16,364
+1,795
+12% +$200K 0.55% 61
2016
Q3
$1.52M Sell
14,569
-8
-0.1% -$835 0.47% 65
2016
Q2
$1.42M Buy
14,577
+1,471
+11% +$139K 0.43% 69
2016
Q1
$1.26M Buy
13,106
+406
+3% +$36.9K 0.4% 69
2015
Q4
$1.15M Buy
12,700
+3,740
+42% +$352K 0.37% 75
2015
Q3
$831K Buy
8,960
+2,240
+33% +$213K 0.28% 82
2015
Q2
$625K Buy
6,720
+3,645
+119% +$340K 0.2% 94
2015
Q1
$291K Sell
3,075
-50
-2% -$4.63K 0.1% 135
2014
Q4
$277K Sell
3,125
-75
-2% -$6.36K 0.09% 138
2014
Q3
$256K Buy
+3,200
New +$241K 0.09% 143

Other funds holding CME

J.W. Burns & Co's CME Position: Q2 2026 in Review

J.W. Burns & Co reduced its CME Group (CME) stake by 2.2% in Q2 2026, selling an estimated $71.9K and leaving 11,468 shares worth $2.53M. The position accounts for 0.26% of the portfolio, ranked #68.

J.W. Burns & Co first reported a position in CME in Q3 2014 and has held it in 48 quarters since. The position peaked at $4.53M in Q1 2022. 222 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • J.W. Burns & Co held 11,468 shares of CME Group worth $2.53M as of Q2 2026.
  • J.W. Burns & Co sold 260 CME Group shares in Q2 2026, an estimated $71.9K.
  • CME Group made up 0.26% of J.W. Burns & Co's portfolio in Q2 2026, its #68 holding.
  • J.W. Burns & Co first reported a position in CME Group in Q3 2014 and has held it in 48 quarters since.
  • J.W. Burns & Co's CME Group position peaked at $4.53M in Q1 2022.
  • 222 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on J.W. Burns & Co's 13F filing for Q2 2026, filed 15 Jul 2026.